Search Results - "Homšak, Evgenija"

Refine Results
  1. 1

    Metabolic Syndrome, Inflammation, Oxidative Stress, and Vitamin D Levels in Children and Adolescents with Obesity by Hertiš Petek, Tjaša, Homšak, Evgenija, Svetej, Mateja, Marčun Varda, Nataša

    “…Metabolic syndrome (MetS) is associated with systemic inflammation, oxidative stress, and hypovitaminosis D. Our aim was to determine whether vitamin D…”
    Get full text
    Journal Article
  2. 2

    New Flow Cytometric Methods for Monitoring STAT5 Signaling Reveal Responses to SARS-CoV-2 Antigen-Specific Stimulation in FOXP3+ Regulatory T Cells also in Patients with Advanced Chronic Lymphocytic Leukemia by Roškar, Zlatko, Dreisinger, Mojca, Tič, Primož, Homšak, Evgenija, Bevc, Sebastjan, Goropevšek, Aleš

    Published in Biosensors (Basel) (11-05-2023)
    “…Increased frequency of CD4 CD25 regulatory T-cells (Treg) has been associated with disease progression in chronic lymphocytic leukemia (CLL). Flow cytometric…”
    Get full text
    Journal Article
  3. 3

    The European Register of Specialists in Clinical Chemistry and Laboratory Medicine: code of conduct, version 3 - 2023 by Queraltó, Josep, Brady, Jennifer, Carobene, Anna, Homšak, Evgenija, Wieringa, Gijsbert

    Published in Clinical chemistry and laboratory medicine (25-05-2023)
    “…Whilst version 2 focussed on the professional conduct expected of a Specialist in Laboratory Medicine, version 3 builds on the responsibilities for ethical…”
    Get more information
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7

    The Impact of Extracorporeal Magnetic Stimulation as Addition to Mirabegron in Overactive Bladder Treatment in Women: A Single-Centre Randomized Sham-Controlled Study by Bele, Uros, Serdinšek, Tamara, Homšak, Evgenija, But, Igor

    Published in Journal of clinical medicine (01-02-2024)
    “…The purpose of our prospective, single-blinded, randomized, sham-controlled study was to investigate the effect of the additional extracorporeal magnetic…”
    Get full text
    Journal Article
  8. 8

    Practice in financial support of third party organised conferences and courses at a national level for health care professionals in Europe by Pašalić, Daria, Homšak, Evgenija, Buño, Antonio, Bergmann, Katarzyna, Carru, Ciriaco

    Published in Clinical chemistry and laboratory medicine (01-09-2019)
    “…Background Ethical MedTech prescribes high standards for the participation of the in vitro diagnostics (IVD) industry in third-party organised educational…”
    Get more information
    Journal Article
  9. 9

    EFLM Project "Exchange of Practical Knowledge and Skills in Laboratory Medicine" - EFLMLabX by Homšak, Evgenija

    Published in EJIFCC (01-11-2018)
    “…In many laboratories/institutions of the European Federation for Clinical Chemistry and Laboratory Medicine (EFLM) there is a need to acquire additional…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12

    Soluble ST2: A complex and diverse role in several diseases by Homsak, Evgenija, Gruson, Damien

    Published in Clinica chimica acta (01-08-2020)
    “…The Suppression of Tumorigenicity 2 protein (ST2) is a member of the interleukin (IL) 1 receptor family with transmembrane (ST2L) and soluble (sST2) isoforms…”
    Get full text
    Journal Article
  13. 13

    Implementing a New Cardiac Biomarker: Keys for Successes by Homsak, Evgenija

    Published in Indian journal of clinical biochemistry (24-05-2022)
    “…Cardiac biomarkers are important tools in a combination with other clinical or imaging methods for managing several cardiovascular diseases (CVD) that concern…”
    Get full text
    Journal Article
  14. 14

    Autoantibodies pANCA, GAB and PAB in inflammatory bowel disease: prevalence, characteristics and diagnostic value by Homsak, Evgenija, Micetić-Turk, Dusanka, Bozic, Borut

    Published in Wiener Klinische Wochenschrift (01-05-2010)
    “…Summary BACKGROUND: The diagnosis of inflammatory bowel disease (IBD), particularly the differentiation between ulcerative colitis (UC) and Crohn's disease…”
    Get full text
    Journal Article
  15. 15

    ST2 as a novel prognostic marker in end-stage renal disease patients on hemodiafiltration by Homsak, Evgenija, Ekart, Robert

    Published in Clinica chimica acta (01-02-2018)
    “…Patients with end-stage renal disease (ESRD) are prone to severe heart failure (HF) and to several life-threatening events. Therefore, the ability to assess…”
    Get full text
    Journal Article
  16. 16

    Hemodiafiltration affects NT-proBNP but not ST2 serum concentration in end-stage renal disease patients by Homsak, Evgenija, Ekart, Robert

    Published in Clinical biochemistry (01-10-2016)
    “…Amino-terminal pro-B-type natriuretic peptide (NT-proBNP) is already established, and soluble ST2 (sST2) is a new promising marker, for evaluating and…”
    Get full text
    Journal Article
  17. 17

    Topni receptor ST2 kot prognostični označevalec pri bolnikih s kronično ledvično boleznijo by Homšak, Evgenija

    Published 01-01-2019
    “…Izhodišča: Bolniki s kronično ledvično boleznijo (KLB) in še posebej dializni bolniki (KLB 5D) so izpostavljeni visokemu tveganju za razvoj srčnega popuščanja…”
    Get full text
    Dissertation
  18. 18

    Measurement of anti-Mullerian hormone: Performances of a new ultrasensitive immunoassay by Gruson, Damien, Homsak, Evgenija

    Published in Clinical biochemistry (01-04-2015)
    “…The measurement of anti-Mullerian hormone (AMH) is relevant for the evaluation of primary ovarian insufficiency, success of assisted reproductive therapies,…”
    Get full text
    Journal Article
  19. 19
  20. 20